IP Library › Granted Patent US 8,961,472
Granted Patent B2
US 8,961,472 · App. 11/680,638 · Granted Feb 24, 2015

Method of assembly of drug delivery devices

Inventors: Robert Veasey (Leamington Spa, GB); Steven Wimpenny (Warwickshire, GB)
Assignee: Sanofi-Aventis Deutschland GmbH
A61M5/31593A61M5/24A61M5/31541A61M5/31551A61M5/31558A61M5/31561A61M5/31585A61M2205/581A61M2205/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,961,472
App. No.
11/680,638
Granted
Feb 24, 2015
Kind
B2
Abstract

The present invention relates to a method for the assembly of drug delivery devices, in particular of pen-type drug delivery devices, having a dose dial mechanism and a drive mechanism, enabling the administration of medicinal products from a multidose cartridge and the drug delivery devices obtainable according to the said method.

Claims (23)

1. A method of assembling a drug delivery device comprising the steps of

a) providing a single one piece unitary housing having a first end and a second end, a cartridge, a drive mechanism, a dose dial mechanism, and optionally a drug delivery mechanism; and

b) inserting or introducing into the second end of the unitary housing the cartridge, the drive mechanism, the dose dial mechanism, and optionally the drug delivery mechanism, whereby said cartridge, said drive mechanism, said dose dial mechanism, and optionally said drug delivery mechanism are not mechanically engaged with the said unitary housing,

wherein the unitary housing forms a single drug delivery outer housing that covers the cartridge, the drive mechanism, the dose dial mechanism, and optionally the drug delivery mechanism of the drug delivery device after assembly and allows delivery of a set dose of a drug to be dispensed through the first end of the one piece unitary housing.

2. The method of assembling a drug delivery device according to claim 1 , wherein the cartridge is first inserted or introduced into the unitary housing followed by insertion or introduction of the drive mechanism, the dose dial mechanism, and optionally the drug delivery mechanism into the unitary housing.

3. The method of assembling a drug delivery device according to claim 2 , wherein one or more components of the drug delivery device are pre-assembled or modular.

4. The method of assembling a drug delivery device according to claim 2 , wherein one or more components of the drug delivery device, selected from the cartridge, the drive mechanism, the dose dial mechanism, and optionally the drug delivery mechanism, or components of said cartridge, drive mechanism, dose dial mechanism, or drug delivery mechanism, are pre-assembled or modular.

5. The method of assembling a drug delivery device according to claim 2 , wherein the unitary housing is of pen-type or non-pen type shape.

6. The method of assembling a drug delivery device according to claim 2 , wherein the cartridge comprises a pharmaceutical formulation for subcutaneous or intramuscular administration.

7. The method of assembling a drug delivery device according to claim 1 , wherein one or more components of the drug delivery device are pre-assembled or modular.

8. The method of assembling a drug delivery device according to claim 1 , wherein one or more components of the drug delivery device, selected from the cartridge, the drive mechanism, the dose dial mechanism, and optionally the drug delivery mechanism, or components of said cartridge, drive mechanism, dose dial mechanism, or drug delivery mechanism, are pre-assembled or modular.

9. The method of assembling a drug delivery device according to claim 1 , wherein the unitary housing is of pen-type or non-pen type shape.

10. The method of assembling a drug delivery device according to claim 1 , wherein the cartridge comprises a pharmaceutical formulation for subcutaneous or intramuscular administration.

11. The method of assembling a drug delivery device according to claim 1 , wherein

the cartridge comprises insulin or a derivative or analogue thereof.

12. The method of assembling a drug delivery device according to claim 1 , wherein the cartridge comprises heparin or a derivative or analogue thereof.

13. A drug delivery device assembled according to the method according to claim 1 .

14. The drug delivery device according to claim 13 , which is a pen-type or a nonpen-type injector.

15. The drug delivery device according to claim 13 , comprising a pharmaceutical formulation for subcutaneous or intramuscular administration.

16. The drug delivery device according to claim 13 , comprising insulin or a derivative or analogue thereof.

17. The drug delivery device according to claim 13 , comprising heparin or a derivative or analogue thereof.

18. The method of assembling a drug delivery device according to claim 1 , wherein

a cap is releasably secured to the first end of the unitary housing to cover a needle unit of the drug delivery device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2007
From: VEASEY, ROBERT; WIMPENNY, STEVEN
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 019355/0489 →
Priority Claims (1)
EP 04020877 · Sep 2, 2004 · regional
Continuity (2)
Continuation PCTEP2005009217 · Aug 26, 2005
Related Publication 20080015511A1 · Jan 17, 2008